These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35758348)

  • 1. Prognostic significance of A-kinase interacting protein 1 expression in various cancers: A meta-analysis based on the Chinese population.
    Xue S; Zhang C; Xu J; Zhou C
    Medicine (Baltimore); 2022 Jun; 101(25):e29203. PubMed ID: 35758348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.
    Chen H; Yan S; Dong L; Li X
    J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AKIP1 expression in tumor tissue as a new biomarker for disease monitoring and prognosis in non-small cell lung cancer: Results of a retrospective study.
    Liu Y; Tian J; Qin D; Liu J; Xie Y
    J Clin Lab Anal; 2020 Apr; 34(4):e23128. PubMed ID: 31782840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A-kinase interacting protein 1 as a potential biomarker of advanced tumor features and increased recurrence risk in papillary thyroid carcinoma patients.
    Zhang L; Tao H; Ke K; Ma C
    J Clin Lab Anal; 2020 Oct; 34(10):e23452. PubMed ID: 32643206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A-kinase interacting protein 1 (AKIP1) associates with advanced overall disease condition, tumor properties, and unfavorable prognosis in hepatocellular carcinoma patients.
    Fang T; Lu Q
    J Clin Lab Anal; 2020 Jun; 34(6):e23213. PubMed ID: 32133702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of a kinase interacting protein 1 in tongue squamous cell carcinoma correlates with lymph node metastasis and poor overall survival.
    Sun Y; Shi G; Ma C; Jiao J; Liu Y; Gao Q; Zhang X; Feng Q
    Medicine (Baltimore); 2021 Apr; 100(14):e25278. PubMed ID: 33832094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
    Zhang X; Liu S; Zhu Y
    Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Sphingosine Kinase 1 Expression Is Associated with Poor Prognosis in Human Solid Tumors: A Meta-Analysis.
    Zhang C; Zhou C; Xu J; Xue S
    Dis Markers; 2022; 2022():8443932. PubMed ID: 35126792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Alpha B-crystallin expression and prognosis in patients with solid tumors: A protocol for systematic review and meta-analysis.
    Yang M; Li Y; Tian F
    Medicine (Baltimore); 2021 Feb; 100(7):e24831. PubMed ID: 33607849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of A-kinase interacting protein 1 as a potential biomarker for risk and prognosis of acute myeloid leukemia.
    Yan Y; Li X; Gao J
    J Clin Lab Anal; 2020 May; 34(5):e23055. PubMed ID: 32356617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
    Chen D; Cao G; Liu Q
    J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A-kinase interacting protein 1 is sufficiently expressed and positively associates with WHO grade, meanwhile predicts unfavorable overall survival independently in glioma patients.
    Shen S; Yao Y
    Medicine (Baltimore); 2021 Jan; 100(4):e20426. PubMed ID: 33530151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
    Zhang S; Qiu D; Xie X; Shen Y
    BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
    Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
    BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A-kinase interacting protein 1, a potential biomarker associated with advanced tumor features and CXCL1/2 in prostate cancer.
    Wang D; Luo Y; Guo Y; Li G; Li F
    Int J Biol Markers; 2020 Jun; 35(2):74-81. PubMed ID: 32339056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis.
    Hu L; Huang M; Yuan Q; Kong F
    Medicine (Baltimore); 2021 Apr; 100(15):e25441. PubMed ID: 33847647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.
    Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L
    Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
    Zhang B; Xie Z; Li B
    Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
    Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
    BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.